Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Smarter Naturally is a UK-based health-tech company and spin-out from the Quadram Institute that develops functional food products to support metabolic health. The company's flagship product is a super-broccoli soup made from a proprietary variety called GRextra, which contains significantly higher levels of glucoraphanin than standard broccoli. Glucoraphanin is converted in the body to sulforaphane, a bioactive compound that helps maintain healthy blood sugar levels and supports cellular metabolism. Backed by decades of clinical research, Smarter Naturally targets individuals with pre-diabetes and Type 2 diabetes, as well as those interested in preventative health. The company operates at the intersection of nutrition and biotechnology, leveraging plant breeding and clinical science to address chronic health conditions. Their products are designed to be integrated into a daily diet as a non-pharmacological intervention for glucose management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Smarter Naturally.